• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受抗甲状腺药物治疗的格雷夫斯病患者中,心理因素与甲状腺功能亢进症预后的关系。

The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.

作者信息

Fukao Atsushi, Takamatsu Junta, Murakami Yasuhiro, Sakane Sadaki, Miyauchi Akira, Kuma Kanji, Hayashi Shunichiro, Hanafusa Toshiaki

机构信息

First Department of Internal Medicine, Osaka Medical College, Takatsuki-city, Japan.

出版信息

Clin Endocrinol (Oxf). 2003 May;58(5):550-5. doi: 10.1046/j.1365-2265.2003.01625.x.

DOI:10.1046/j.1365-2265.2003.01625.x
PMID:12699435
Abstract

OBJECTIVE

The relationship between emotional stress and the onset of hyperthyroidism has been well investigated, but the relationship between psychological factors and prognosis of antithyroid drug-treated hyperthyroidism is not well known. This study has examined not only emotional stresses but also patients' personality traits using specific tests.

DESIGN

A prospective cohort study.

SUBJECTS

Sixty-nine patients with hyperthyroid Graves' disease in the euthyroid state after 2-5 years of antithyroid drug therapy and 32 healthy subjects as the control group.

MEASUREMENTS

Patients responded to three types of questionnaires, including the Minnesota Multiphasic Personality Inventory for personality traits, the Natsume's Stress Inventory for major life events, and the Hayashi's Daily Life Stress Inventory for daily life stresses.

RESULTS

In the Graves' disease patients, stress scores of life events correlated significantly with serum TSH receptor antibody activity (r = 0.424, P < 0.001) and thyroid volume (r = 0.480, P < 0.001). When the patients were divided according to prognosis (41 with relapse and 28 with remission), four personality traits including hypochondriasis, depression, paranoia and psychasthenia (mental fatigue) were significantly (P = 0.0146, 0.0052, 0.0125, and 0.0186, respectively) more common in the relapsed Graves' disease group than those of the remitted group. Six personality traits of conversion hysteria, psychopathic deviation, masculinity and feminity, schizophrenia, hypomania, and social introversion were not significantly different between the two groups. The scores of daily hassles (problems of daily life) were also significantly (P = 0.0124) greater in the relapsed Graves' disease group than in the remitted group. The scale scores of depression and psychasthenia showed a positive correlation with scores of daily hassles (r = 0.535, P < 0.0001; r = 0.580, P < 0.0001, respectively), while an inverse correlation with scores of daily uplifts (r = -0.373, P = 0.0332; r = -0.322, P = -0.0120, respectively).

CONCLUSIONS

The results suggest that major life events, personality traits of hypochondriasis and depression, paranoia, mental fatigue, and daily problems aggravate the prognosis of antithyroid drug-treated hyperthyroidism. Escape from life events is virtually impossible; thus coping strategies suggested by the physician may be useful in improving prognosis in Graves' disease.

摘要

目的

情绪应激与甲状腺功能亢进症发病之间的关系已得到充分研究,但心理因素与抗甲状腺药物治疗的甲状腺功能亢进症预后之间的关系尚不清楚。本研究不仅使用特定测试检查了情绪应激,还研究了患者的人格特质。

设计

前瞻性队列研究。

研究对象

69例接受抗甲状腺药物治疗2 - 5年后处于甲状腺功能正常状态的格雷夫斯病甲状腺功能亢进症患者,以及32名健康受试者作为对照组。

测量方法

患者对三种问卷进行了回答,包括用于人格特质的明尼苏达多相人格调查表、用于重大生活事件的夏目应激量表,以及用于日常生活应激的林氏日常生活应激量表。

结果

在格雷夫斯病患者中,生活事件的应激评分与血清促甲状腺激素受体抗体活性显著相关(r = 0.424,P < 0.001)和甲状腺体积(r = 0.480,P < 0.001)。当根据预后将患者分组时(41例复发,28例缓解),包括疑病症、抑郁症、偏执狂和精神衰弱(精神疲劳)在内的四种人格特质在复发的格雷夫斯病组中比缓解组显著更常见(P分别为0.0146、0.0052、0.0125和0.0186)。转换性癔症、精神病态偏差、男性化与女性化、精神分裂症、轻躁狂和社交内向这六种人格特质在两组之间没有显著差异。复发的格雷夫斯病组的日常烦恼(日常生活问题)得分也显著高于缓解组(P = 0.0124)。抑郁和精神衰弱的量表得分与日常烦恼得分呈正相关(r分别为0.535,P < 0.0001;r = 0.580,P < 0.0001),而与日常愉悦得分呈负相关(r分别为 - 0.373,P = 0.0332;r = - 0.322,P = - 0.0120)。

结论

结果表明,重大生活事件、疑病症和抑郁症的人格特质偏执狂、精神疲劳和日常问题会加重抗甲状腺药物治疗的甲状腺功能亢进症的预后。逃避生活事件几乎是不可能的;因此医生建议的应对策略可能有助于改善格雷夫斯病的预后。

相似文献

1
The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.在接受抗甲状腺药物治疗的格雷夫斯病患者中,心理因素与甲状腺功能亢进症预后的关系。
Clin Endocrinol (Oxf). 2003 May;58(5):550-5. doi: 10.1046/j.1365-2265.2003.01625.x.
2
The thyroid function of Graves' disease patients is aggravated by depressive personality during antithyroid drug treatment.在抗甲状腺药物治疗期间,Graves 病患者的抑郁人格会加重其甲状腺功能。
Biopsychosoc Med. 2011 Aug 9;5:9. doi: 10.1186/1751-0759-5-9.
3
Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.停用抗甲状腺药物治疗一个月后进行促甲状腺素和促甲状腺素受体抗体检测,以此作为格雷夫斯病复发的预测指标。
Thyroid. 2005 Sep;15(9):1047-54. doi: 10.1089/thy.2005.15.1047.
4
Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.采用人促甲状腺激素受体的新型促甲状腺激素结合抑制活性测定法在抗甲状腺药物治疗的格雷夫斯病随访中的临床价值。与促甲状腺激素刺激抗体生物测定法的比较。
Clin Endocrinol (Oxf). 2001 Jan;54(1):89-96. doi: 10.1046/j.1365-2265.2001.01197.x.
5
Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.277例格雷夫斯病患者及686名正常受试者体内的促甲状腺素抗体和促甲状腺素结合抑制性免疫球蛋白
J Endocrinol Invest. 1997 Sep;20(8):452-61. doi: 10.1007/BF03348001.
6
Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.在 Graves 病患者中,使用甲巯咪唑进行抗甲状腺药物治疗时发生甲状腺功能减退症是一个有利的预后指标。
Thyroid. 2010 Sep;20(9):949-54. doi: 10.1089/thy.2009.0126.
7
Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.抗甲状腺药物治疗成功后Graves病的复发:一项关于左甲状腺素使用的前瞻性随机研究结果
Thyroid. 2002 Dec;12(12):1119-28. doi: 10.1089/105072502321085225.
8
Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.尽管促甲状腺激素结合抑制性免疫球蛋白检测结果迅速转阴,但仍存在持续性格雷夫斯甲亢:一例报告
J Med Case Rep. 2017 Feb 6;11(1):32. doi: 10.1186/s13256-017-1214-6.
9
Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.评估血清基础促甲状腺激素水平和促甲状腺激素受体抗体活性作为Graves病患者停用抗甲状腺药物治疗的预后标志物。
Clin Endocrinol (Oxf). 1992 Jun;36(6):585-90. doi: 10.1111/j.1365-2265.1992.tb02269.x.
10
Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.促甲状腺素受体自身抗体与接受治疗的甲状腺功能正常的格雷夫斯病患者持续的促甲状腺素抑制有关。
J Clin Endocrinol Metab. 2003 Sep;88(9):4135-8. doi: 10.1210/jc.2003-030430.

引用本文的文献

1
Psychological aspects of Graves' ophthalmopathy.格雷夫斯眼病的心理学方面
Endocr Connect. 2024 Aug 12;13(9). doi: 10.1530/EC-24-0259. Print 2024 Sep 1.
2
Evaluation of YouTube As A Source For Graves' Disease Information: Is High-Quality Guideline-Based Information Available?评估YouTube作为格雷夫斯病信息来源:是否有基于高质量指南的信息?
OTO Open. 2024 Mar 19;8(1):e118. doi: 10.1002/oto2.118. eCollection 2024 Jan-Mar.
3
What is the impact of stress on the onset and anti-thyroid drug therapy in patients with graves' disease: a systematic review and meta-analysis.
压力对格雷夫斯病患者发病和抗甲状腺药物治疗的影响:系统评价和荟萃分析。
BMC Endocr Disord. 2023 Sep 12;23(1):194. doi: 10.1186/s12902-023-01450-y.
4
Prediction for recurrence following antithyroid drug therapy for Graves' hyperthyroidism.格雷夫斯甲亢抗甲状腺药物治疗后复发的预测。
Arch Endocrinol Metab. 2023 May 12;67(4):e000609. doi: 10.20945/2359-3997000000609.
5
Patient needs and care: moves toward person-centered care for Graves' disease in Sweden.患者需求与护理:瑞典 Graves 病护理模式向以患者为中心转变。
Eur Thyroid J. 2023 Apr 21;12(3). doi: 10.1530/ETJ-23-0010. Print 2023 Jun 1.
6
Stress-Related Immune Response and Selenium Status in Autoimmune Thyroid Disease Patients.自身免疫性甲状腺疾病患者的应激相关免疫反应和硒状态。
Int J Mol Sci. 2023 Jan 26;24(3):2440. doi: 10.3390/ijms24032440.
7
The Utilization of Chinese Herbal Products for Hyperthyroidism in National Health Insurance System (NHIRD) of Taiwan: A Population-Based Study.台湾全民健康保险系统(NHIRD)中用于治疗甲状腺功能亢进的中草药产品的使用情况:一项基于人群的研究。
Evid Based Complement Alternat Med. 2022 Mar 19;2022:5500604. doi: 10.1155/2022/5500604. eCollection 2022.
8
Relationship Between Loneliness and Hypothyroidism.孤独与甲状腺功能减退症之间的关系。
Cureus. 2021 Nov 28;13(11):e19955. doi: 10.7759/cureus.19955. eCollection 2021 Nov.
9
Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease.甲状腺特异性生活质量问卷ThyPRO在新加坡格雷夫斯病患者中的心理测量学特性。
J Patient Rep Outcomes. 2021 Jul 8;5(1):54. doi: 10.1186/s41687-021-00309-x.
10
Graves' disease and mental disorders.格雷夫斯病与精神障碍
J Clin Transl Endocrinol. 2019 Oct 11;19:100207. doi: 10.1016/j.jcte.2019.100207. eCollection 2020 Mar.